We are committed to providing a website that is accessible to the widest possible audience. To do so, we are actively working with consultants to update the website by increasing its accessibility and usability by persons who use assistive technologies
such as automated tools, keyboard-only navigation, and screen readers.
We are working to have the website conform to the relevant standards of the Section 508 Web Accessibility Standards developed by the United States Access Board, as
well as the World Wide Web Consortium's (W3C) Web Content Accessibility Guidelines 2.1. These standards and guidelines explain how to make web content more accessible for people with disabilities. We believe that conformance with these standards and
guidelines will help make the website more user friendly for all people.
Our efforts are ongoing. While we strive to have the website adhere to these guidelines and standards, it is not always possible to do so in all areas of the website.
If, at any time, you have specific questions or concerns about the accessibility of any particular webpage, please contact WebsiteAccess@tenethealth.com so that we may be of assistance.
Deep-seated brain tumors and blood clots have always posed a challenge for neurosurgeons. While they could reach the tumors, they risked damaging the surrounding tissues where nerves control body functions like movement, memory, vision, and speech.
BrainPath offers a new way forward.
First, the neurosurgeon reviews the BrightMatter™ planning software advanced imaging to map in detail the tumor or clot in the brain, as well as the tissue and millions of white matter brain fibers surrounding it. Think of it as studying a color photo instead of one that’s just black and white.
The imaging is combined with a precision navigation system that guides the neurosurgeon, in real time, to the tumor or blood clot. Then, the neurosurgeon enters the brain through a small opening with the BrainPath device. Its cone-shaped sheath safely
pushes aside the dense and sensitive white matter tracts of neural networks and serves as a protective portal so the neurosurgeon can more easily access the tumor or clot.
Next, using high-powered optics, the neurosurgeon inserts another automated tool, the NICO Myriad, through the sheath. The device - which is about the diameter of a pencil - is used to remove only the targeted tissue without injuring nearby brain structures.
Our neurosurgeons are able to reach the deepest recesses of the brain, and this advanced process may result in less blood loss and faster recovery for patients.
What’s more, a filter on the Myriad device also allows the neurosurgeon to capture sterile, intact tissue that can be studied later by clinicians and researchers.
Dr. Marco Marsella, an independent neurosurgeon* on staff at Abrazo Central
Campus, is the first Arizona physician trained to use the BrainPath tool.
"With this technology, we may approach tumors that were considered hard to remove or whose resection would pose a high intraoperative risk," Dr. Marsella said. "Benefits of this device include safer surgery, that usually provides faster recovery time, minimal internal and external scarring, less trauma to the brain and nerves, fewer side effects and complications post-surgery."
What conditions can BrainPath treat?
This revolutionary tool allows our neurosurgeons to safely reach a wide variety of previously inoperable tumors and blood clots.
Glioblastoma multiforme (GBM), the most common and deadly type of malignant brain tumor
Other primary brain tumors and cysts
Metastatic brain tumors, secondary tumors that occur elsewhere in the body and migrate to the brain
Intracerebral hemorrhage or hemorrhagic stroke
Hemorrhage from traumatic brain injury
For more information on BrainPath and Abrazo Central Campus, please call 602-249-0212.
Independent Neurosurgeons on staff at Abrazo Central Campus trained to perform BrainPath include Dr. Marco Marsella
*Please note: Only physicians who have appropriate medical staff privileges at Abrazo Central Campus may participate in this program. These independent physicians are not employees, agents or representatives of Abrazo Central Campus and are solely responsible for the provision of their medical services to you.
Is there hope for me?
You’ve received an unimaginable diagnosis – a brain tumor or life-threatening blood clot – and traditional brain surgery poses so many risks. At Abrazo Health’s Abrazo Central Campus, we offer patients a less-invasive
surgical option using NICO BrainPath. This sophisticated tool enables our neurosurgeons to navigate between the natural folds and neural structures in the brain without cutting or damaging anything else in its path.
The result: An incision just about the size of a dime. Decreased surgical risks. The chance for a faster recovery.
We are the first in Arizona to use this state-of-the art technology and are caring for patients with previously inoperable brain conditions.
A second chance at life.
Edward Cerninka spent 30 years painting houses in the Phoenix historic district. Thanks to Dr. Marco Marsella and the BrainPath surgical tool used at Abrazo Central Campus,
not even a brain tumor could stop him from doing what he loves.
“With this NICO BrainPath technology, we may approach tumors that were considered hard to remove or whose resection would pose a high intraoperative risk,’’
said Neurosurgeon Marco Marsella who is the only Arizona physician trained to use the NICO BrainPath device.
“It was a miracle surgery,” Edward says. “I still can’t believe that a tumor the size of a golf ball was in
my head! And that I was well enough to go home just two days after having my brain tumor removed.”
"This is a dialog window which overlays the main content of the page and plays an embedded YouTube video. Pressing the Close Modal button at the bottom of the modal or pressing the Escape key will close the modal and bring you back to where you were on the page.